These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37909473)

  • 1. Molecular level investigation for identifying potential inhibitors against thymidylate kinase of monkeypox through
    Koirala S; Samanta S; Mahapatra S; Ursal KD; Poddar S; Kar P
    J Biomol Struct Dyn; 2023 Nov; ():1-14. PubMed ID: 37909473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
    Sib Tul Hassan Shah S; Naeem I
    J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
    Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
    J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design of promising natural products to inhibit thymidylate kinase from Monkeypox virus and validation using free energy calculations.
    Khan A; Adil S; Qudsia HA; Waheed Y; Alshabrmi FM; Wei DQ
    Comput Biol Med; 2023 May; 158():106797. PubMed ID: 36966556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Inhibitors of Monkeypox Virus Revealed by Molecular Modeling Approach to Viral DNA Topoisomerase I.
    Hu X; An S; Chu J; Liang B; Liao Y; Jiang J; Lin Y; Ye L; Liang H
    Molecules; 2023 Feb; 28(3):. PubMed ID: 36771105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the myxobacterial secondary metabolites Aurachin A and Soraphinol A as promising inhibitors of thymidylate kinase of the Monkeypox virus.
    Ali Y; Khan AA; Alanazi AM; Abdikakharovich SA; Shah JA; Ren ZG; Khattak S
    Mol Divers; 2024 Jan; ():. PubMed ID: 38183513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from
    Garcia DR; Souza FR; Guimarães AP; Valis M; Pavelek Z; Kuca K; Ramalho TC; França TCC
    Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681251
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lokhande KB; Shrivastava A; Singh A
    J Biomol Struct Dyn; 2023; 41(23):14259-14274. PubMed ID: 36841550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of Microbially Derived Natural Compounds against Monkeypox Virus as Viral Core Cysteine Proteinase Inhibitors.
    Dubey A; Alawi MM; Alandijany TA; Alsaady IM; Altwaim SA; Sahoo AK; Dwivedi VD; Azhar EI
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
    Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
    Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cheminformatics and machine learning approaches for repurposing anti-viral compounds against monkeypox virus thymidylate kinase.
    Rabaan AA; Alwashmi ASS; Mashraqi MM; Alshehri AA; Alawfi A; Alshengeti A; Najim MA; AlShehail BM; AlShahrani AJ; Garout M
    Mol Divers; 2023 Aug; ():. PubMed ID: 37531040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring molecular interactions of potential inhibitors against the spleen tyrosine kinase implicated in autoimmune disorders via virtual screening and molecular dynamics simulations.
    Samanta S; Sk MF; Koirala S; Kar P
    SAR QSAR Environ Res; 2023 Oct; ():1-29. PubMed ID: 37881946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating biophysical basis of binding of inhibitors to SARS-CoV-2 main protease by using molecular dynamics simulations and free energy calculations.
    Sk MF; Roy R; Jonniya NA; Poddar S; Kar P
    J Biomol Struct Dyn; 2021 Jul; 39(10):3649-3661. PubMed ID: 32396767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
    Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
    J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Podduturi S; Vemula D; Singothu S; Bhandari V
    J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37555596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of HDAC8-ligands' intermolecular forces through molecular dynamics simulations: profiling of non-bonding energies to design potential compounds as new anti-cancer agents.
    Dewaker V; Srivastava AK; Arora A; Prabhakar YS
    J Biomol Struct Dyn; 2021 Aug; 39(13):4726-4751. PubMed ID: 32578494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational insights into pediatric adenovirus inhibitors:
    Sarkar K; Nandi S; Das RK
    J Biomol Struct Dyn; 2023 Aug; ():1-14. PubMed ID: 37642990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A chemoinformatic-biophysics based approach to identify novel anti-virulent compounds against
    Al-Harbi AI; Ullah A; Almanaa TN; Gul F; Khan S; Waheed Y; Ul Haq M; Muhammad R; Khurram M; Ullah A; Ahmad S
    J Biomol Struct Dyn; 2023 Aug; ():1-10. PubMed ID: 37551016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery of novel antivirals for the treatment of mpox: is drug repurposing the answer?
    Ezat AA; Abduljalil JM; Elghareib AM; Samir A; Elfiky AA
    Expert Opin Drug Discov; 2023 May; 18(5):551-561. PubMed ID: 37032577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular insights to the binding interactions of APNS containing HIV-protease inhibitors against SARS-CoV-2 M
    Purohit P; Dash JJ; Muya JT; Meher BR
    J Biomol Struct Dyn; 2023 Jun; 41(9):3900-3913. PubMed ID: 35388744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.